0001209191-22-049721.txt : 20220913
0001209191-22-049721.hdr.sgml : 20220913
20220913165956
ACCESSION NUMBER: 0001209191-22-049721
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220909
FILED AS OF DATE: 20220913
DATE AS OF CHANGE: 20220913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schor Chen
CENTRAL INDEX KEY: 0001340875
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38359
FILM NUMBER: 221241340
MAIL ADDRESS:
STREET 1: PREDIX PHARMACEUTICALS HOLDINGS, INC.
STREET 2: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adicet Bio, Inc.
CENTRAL INDEX KEY: 0001720580
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813305277
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: 19TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-482-2333
MAIL ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: 19TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: resTORbio, Inc.
DATE OF NAME CHANGE: 20171024
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-09
0
0001720580
Adicet Bio, Inc.
ACET
0001340875
Schor Chen
C/O ADICET BIO, INC.
200 BERKELEY STREET, 19TH FLOOR
BOSTON
MA
02116
1
1
0
0
President & CEO
Common Stock
2022-09-09
4
S
0
8094
16.5062
D
66747
I
See Footnote
Common Stock
2022-09-12
4
S
0
66747
16.7694
D
0
I
See Footnote
Common Stock
2022-09-12
4
S
0
200
18.00
D
143060
I
See Footnote
Common Stock
2022-09-13
4
S
0
3371
18.0105
D
139689
I
See Footnote
Common Stock
122712
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $16.50 to $16.56, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission ("SEC") staff upon request.
Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $16.50 to $16.96, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $18.00 to $18.05, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
/s/ Nick Harvey, Attorney-in-Fact
2022-09-13